Press Releases

July 30, 2018 Lupin’s Mandideep facility gets approval from EDQM

July 27, 2018 Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US

July 24, 2018 Lupin receives FDA approval for Fluocinonide Topical Solution

July 19, 2018 Lupin receives tentative FDA approval for generic Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg

July 16, 2018 Lupin’s Goa facility gets approval from UK MHRA

July 12, 2018 Lupin receives FDA approval for generic Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg

July 11, 2018 Boehringer Ingelheim India and Lupin expand collaboration for co-marketing of two oral anti-diabetic drugs

July 10, 2018 Lupin appoints Yashwant Mahadik as President – Global HR

July 9, 2018 Lupin receives FDA approval for generic Hydroxychloroquine Sulfate Tablets USP, 200 mg